Page last updated: 2024-10-28

idebenone and Orphan Diseases

idebenone has been researched along with Orphan Diseases in 2 studies

Orphan Diseases: Rare diseases that have not been well studied.

Research Excerpts

ExcerptRelevanceReference
"Low-quality evidence from two small, published, randomised controlled trials neither support nor refute an effect from antioxidants (idebenone, or a combination of coenzyme Q10 and vitamin E) on the neurological status of people with Friedreich ataxia, measured with a validated neurological rating scale."4.93Pharmacological treatments for Friedreich ataxia. ( Brassington, R; Fahey, M; Kearney, M; Orrell, RW; Pandolfo, M, 2016)
"More than 10 studies used idebenone in the treatment of Friedreich ataxia but only one small RCT, with 29 participants, using the synthetic antioxidant idebenone 5 mg/kg, fulfilled the selection criteria for this review."4.88Antioxidants and other pharmacological treatments for Friedreich ataxia. ( Fahey, M; Kearney, M; Orrell, RW; Pandolfo, M, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kearney, M2
Orrell, RW2
Fahey, M2
Brassington, R1
Pandolfo, M2

Reviews

2 reviews available for idebenone and Orphan Diseases

ArticleYear
Pharmacological treatments for Friedreich ataxia.
    The Cochrane database of systematic reviews, 2016, Aug-30, Issue:8

    Topics: Antioxidants; Friedreich Ataxia; Heart; Humans; Hypertrophy, Left Ventricular; Randomized Controlled

2016
Antioxidants and other pharmacological treatments for Friedreich ataxia.
    The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

    Topics: Antioxidants; Friedreich Ataxia; Humans; Hypertrophy, Left Ventricular; Randomized Controlled Trials

2012